VBIV VBI Vaccines Future Profit

VBI Vaccines, Inc. (VBIV) - corporate logo

The collapse of the partner network and the freezing of investments following bankruptcy have created a critical vacuum for VBI Vaccines Inc. (VBIV). After evaluating the forward profitability trend on GURU.Markets, we find that the value of reflects the current magnitude of market expectations. The potential is based on patent ownership and sales of hepatitis B vaccines, although success depends on government contracts and the recognition of new drugs against brain cancer.

VBIV - VBI Vaccines, Inc. Expected Profit over the range 07/04/2022 - 11/18/2026

VBI Vaccines Inc. - analytical breakdowns and key metrics (VBIV)

- share price and consensus valuation forecast:
Basic company analysis:VBIV, VBI Vaccines Inc
Core merchandise of VBI Vaccines Inc

The reliability of the global cold chain during the transportation of VBI Vaccines Inc. (VBIV) vaccines determines the operational resilience of the business. This metric aggregates current analyst forecasts, transforming quarterly expectations into a daily data stream of potential profit. By analyzing the trajectory of future earnings, the investor observes the dynamics of the asset's fundamental value without time lags. An increase in the indicator confirms the scalability of the logistics network, while declining values signal a revaluation of the company's cost.